International Journal of Infectious Diseases (Jun 2018)
HIV viral suppression in Oman: Encouraging progress toward achieving the United Nations ‘third 90’
- Ali Elgalib,
- Samir Shah,
- Zeyana Al-Habsi,
- Maha Al-Fouri,
- Halima Al-Sawafi,
- Jalila Al-Noumani,
- Adil Al-Baloushi,
- Saad Al-Alawi,
- Salma Al-Badi,
- Zainab Mohammed,
- Jokha Al-Ghafri,
- Asma Suleimani,
- Huda Al-Mashani,
- Jyothish Raju,
- Saada Al-Riyami,
- Muna Al-Shukri,
- Abdul Wahab,
- Bilal Hussain,
- Khalifa Al-Naabi,
- Anantha Narayan,
- Noreen Oliveros,
- George Prasad,
- Ahmed Hussein,
- Rajeev Kashyp,
- Khalid Al-Shardi,
- Ahmed Nada,
- Shakil Akhwand,
- Bina Kamble,
- Kawthar Al-Aamri,
- Suad Al-Mukhaini,
- Hanan Al-Kindi,
- Faryal Khamis,
- Amal Al-Maani,
- Idris Al-Abaidani,
- Seif Al-Abri
Affiliations
- Ali Elgalib
- Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman
- Samir Shah
- Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman
- Zeyana Al-Habsi
- Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman
- Maha Al-Fouri
- Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman
- Halima Al-Sawafi
- Al-Nahdha Hospital, Muscat, Oman
- Jalila Al-Noumani
- Royal Hospital, Muscat, Oman
- Adil Al-Baloushi
- Sohar Polyclinic, Sohar, Oman
- Saad Al-Alawi
- Al-Buraimi Hospital, Al-Buraimi, Oman
- Salma Al-Badi
- Ibri Hospital, Ibri, Oman
- Zainab Mohammed
- Sur Hospital, Sur, Oman
- Jokha Al-Ghafri
- Rustaq Hospital, Rustaq, Oman
- Asma Suleimani
- Nizwa Hospital, Nizwa, Oman
- Huda Al-Mashani
- Sultan Qaboos Hospital, Salalah, Oman
- Jyothish Raju
- Royal Oman Police Hospital, Muscat, Oman
- Saada Al-Riyami
- Army Force Hospital, Muscat, Oman
- Muna Al-Shukri
- Khasab Hospital, Khasab, Oman
- Abdul Wahab
- Khasab Hospital, Khasab, Oman
- Bilal Hussain
- Central Public Health Laboratory, Muscat, Oman
- Khalifa Al-Naabi
- Ibra Hospital, Ibra, Oman
- Anantha Narayan
- Ibra Hospital, Ibra, Oman
- Noreen Oliveros
- Royal Oman Police Hospital, Muscat, Oman
- George Prasad
- Nizwa Hospital, Nizwa, Oman
- Ahmed Hussein
- Rustaq Hospital, Rustaq, Oman
- Rajeev Kashyp
- Al-Buraimi Hospital, Al-Buraimi, Oman
- Khalid Al-Shardi
- Sohar Polyclinic, Sohar, Oman
- Ahmed Nada
- Ibri Hospital, Ibri, Oman
- Shakil Akhwand
- Sultan Qaboos Hospital, Salalah, Oman
- Bina Kamble
- Al-Nahdha Hospital, Muscat, Oman
- Kawthar Al-Aamri
- Army Force Hospital, Muscat, Oman
- Suad Al-Mukhaini
- Sur Hospital, Sur, Oman
- Hanan Al-Kindi
- Central Public Health Laboratory, Muscat, Oman
- Faryal Khamis
- Royal Hospital, Muscat, Oman
- Amal Al-Maani
- Royal Hospital, Muscat, Oman
- Idris Al-Abaidani
- Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman
- Seif Al-Abri
- Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman
- DOI
- https://doi.org/10.1016/j.ijid.2018.04.795
- Journal volume & issue
-
Vol. 71,
no. C
pp. 94 – 99
Abstract
Objective: To assess the impact of capacity-building interventions introduced by the Oman National AIDS Programme on the quality of HIV care in the country. Methods: HIV viral load (VL) suppression and loss to follow-up (LTFU) rates were calculated for the period before (in December 2015; n = 1098) and after (in June 2017; n = 1185) the introduction of the interventions: training, support, and care pathway development. Three HIV VL cuts-offs at last measurement in the year of interest were used to define VL suppression. Results: In the intention-to-treat (ITT) analysis, rates of VL <200 copies/ml and <1000 copies/ml increased from 51.9% in 2015 to 65.5% in 2017 (relative risk (RR) 1.26, 95% confidence interval (CI) 1.17–1.36) and from 58.1% in 2015 to 70.9% in 2017 (RR 1.22, 95% CI 1.14–1.30), respectively; p < 0.0001 for both. Similarly, in the on-treatment analysis, rates of VL <200 copies/ml and <1000 copies/ml increased from 64.2% in 2015 to 76.9% in 2017 (RR 1.20, 95% CI 1.12–1.28) and from 71.9% in 2015 to 83.2% in 2017 (RR 1.16, 95% CI 1.10–1.22), respectively. Fewer patients were LTFU in 2017 than in 2015 (14.7% (157/1061) vs. 19.2% (188/981); RR 0.77, 95% CI 0.64–0.94). Conclusions: Achieving the UNAIDS target of 90% of HIV patients on treatment having VL suppression by 2020 is feasible in Oman.
Keywords